{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients between June 2014 and October 2020 with LARC within 12 cm from the anal verge and uninvolved MRF were randomly assigned"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients between June 2014 and October 2020 with LARC within 12 cm from the anal verge and uninvolved MRF"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to nCT group with 4 cycles of CAPOX... or nCRT group with Capecitabine 825 mg/m\u00b2 twice daily administered orally and concurrently with radiation therapy"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary end point is local-regional recurrence-free survival"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 663 initially enrolled patients, 589 received the allocated treatment (nCT, n=300; nCRT, n=289)"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "589 received the allocated treatment (nCT, n=300; nCRT, n=289)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Pathologic complete response rate was 11.0% (95% CI, 7.8-15.3%) in the nCT arm and 13.8% (95% CI, 10.1-18.5%) in the nCRT arm ( P =0.33)"
      },
      "Harms": {
        "score": 1,
        "evidence": "surgical events, and toxicity"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}